These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1417006)

  • 1. [Radical surgery for ovarian cancer].
    Ochiai K; Takakura S; Kawashima M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1977-81. PubMed ID: 1417006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the comprehensive treatment of ovarian cancer].
    Yakushiji M; Sugiyama T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1855-62. PubMed ID: 2454614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [How radical should surgery in ovarian cancer be?].
    Sevin BU
    Gynakologe; 1986 Jun; 19(2):96-105. PubMed ID: 3525346
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retroperitoneal lymph node metastasis in epithelial cancer of the ovary: a report of 58 cases].
    Xie R; Lin YZ; Chen GL
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):499-501. PubMed ID: 15555344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reassessment of second-look operations (SLO) in the treatment of ovarian cancer].
    Ochiai K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1303-9. PubMed ID: 2730043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic factors of ovarian cancer].
    Ochiai K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of second look surgery in the therapy of ovarian cancer].
    Sasaki H; Ochiai K; Terashima Y
    Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effects of chemotherapy-surgery-chemotherapy regimen on clinically inoperable advanced ovarian cancer.
    Feng Y; Sun T
    Chin Med J (Engl); 1998 Aug; 111(8):722-5. PubMed ID: 11245027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case report of ovarian cancer stage Ia with micrometastasis of para-aortic lymph node].
    Adachi S; Noda T; Hirano Y; Katou Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Nov; 44(11):1459-62. PubMed ID: 1460366
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of surgery for advanced epithelial ovarian cancer].
    Hatae M; Onishi Y; Nakamura T; Wada T
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):201-7. PubMed ID: 9474929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of cytoreductive surgery with lymphadenectomy including para-aortic nodes for advanced ovarian cancer.
    Kigawa J; Minagawa Y; Ishihara H; Kanamori Y; Itamochi H; Terakawa N
    Eur J Surg Oncol; 1993 Jun; 19(3):273-8. PubMed ID: 8314386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of second-look operations (SLO) in ovarian cancer].
    Yuzawa H
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1310-6. PubMed ID: 2658822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximal cytoreductive surgery and high dose cisplatin chemotherapy for advanced ovarian cancer.
    Ochiai K; Takakura S; Isonishi S; Sasaki H; Terashima Y
    Asia Oceania J Obstet Gynaecol; 1993 Dec; 19(4):375-81. PubMed ID: 8135669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 19. [Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
    Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():357-8. PubMed ID: 2693256
    [No Abstract]   [Full Text] [Related]  

  • 20. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
    Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
    J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.